No biological evidence of XMRV in blood or prostatic fluid from prostate cancer patients

PLoS ONE

Volumn 7, Issue 5, 2012, Pages

  Mendoza, Ramon ^a   Silverman, Robert H ^b   Klein, Eric A ^b   Miller, A Dusty ^a,c  

^a Fred Hutchinson Cancer Research Center   (United States)

^b LERNER RESEARCH INSTITUTE   (United States)

^c UNIVERSITY OF WASHINGTON   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

NEUTRALIZING ANTIBODY; VIRUS DNA;

ANTIBODY DETECTION; ARTICLE; BLOOD LEVEL; CANCER PATIENT; CLINICAL ARTICLE; CONTROLLED STUDY; DNA MICROARRAY; HUMAN; HUMAN CELL; MALE; NONHUMAN; PROSTATE CANCER; PROSTATE FLUID; PROSTATE SECRETION; RETROVIRUS INFECTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; VIRUS DETECTION; VIRUS LOAD; VIRUS NEUTRALIZATION; VIRUS REPLICATION; XENOTROPIC MULV RELATED VIRUS; BLOOD; BODY FLUID; IMMUNOLOGY; ISOLATION AND PURIFICATION; POLYMERASE CHAIN REACTION; PROSTATE TUMOR; SERODIAGNOSIS; VIREMIA; VIROLOGY;

XENOTROPIC MURINE LEUKEMIA VIRUS;

ANTIBODIES, NEUTRALIZING; BODY FLUIDS; HUMANS; MALE; NEUTRALIZATION TESTS; POLYMERASE CHAIN REACTION; PROSTATIC NEOPLASMS; VIREMIA; XENOTROPIC MURINE LEUKEMIA VIRUS-RELATED VIRUS;

EID: 84861210993     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0036073     Document Type: Article

References (31)

1. Urisman A, Molinaro RJ, Fischer N, Plummer SJ, Casey G, et al. (2006) Identification of a novel gammaretrovirus in prostate tumors of patients homozygous for R462Q RNASEL variant. PLoS Path 2: e25.
2. Lombardi VC, Ruscetti FW, Das Gupta J, Pfost MA, Hagen KS, et al. (2009) Detection of an infectious retrovirus, XMRV, in blood cells of patients with chronic fatigue syndrome. Science 326: 585-589.
3. Aloia AL, Sfanos KS, Isaacs WB, Zheng Q, Maldarelli F, et al. (2010) XMRV: A new virus in prostate cancer? Cancer Res 70: 10028-10033.
4. Knox K, Carrigan D, Simmons G, Teque F, Zhou Y, et al. (2011) No evidence of murine-like gammaretroviruses in CFS patients previously identified as XMRV-infected. Science 333: 94-97.
5. Knouf EC, Metzger MJ, Mitchell PS, Arroyo JD, Chevillet JR, et al. (2009) Multiple integrated copies and high-level production of the human retrovirus XMRV (xenotropic murine leukemia virus-related virus) from 22Rv1 prostate carcinoma cells. J Virol 83: 7353-7356.
6. Paprotka T, Venkatachari NJ, Chaipan C, Burdick R, Delviks-Frankenberry KA, et al. (2010) Inhibition of xenotropic murine leukemia virus-related virus by APOBEC3 proteins and antiviral drugs. J Virol 84: 5719-5729.
7. Smith RA, Gottlieb GS, Miller AD, (2010) Susceptibility of the human retrovirus XMRV to antiretroviral inhibitors. Retrovirology 7: 70.
8. Paprotka T, Delviks-Frankenberry KA, Cingöz O, Martinez A, Kung HJ, et al. (2011) Recombinant origin of the retrovirus XMRV. Science 333: 97-101.
9. Hue S, Gray ER, Gall A, Katzourakis A, Tan CP, et al. (2010) Disease-associated XMRV sequences are consistent with laboratory contamination. Retrovirology 7: 111.
10. Alberts B, (2011) Retraction. Science 334: 1636.
11. Simmons G, Glynn SA, Komaroff AL, Mikovits JA, Tobler LH, et al. (2011) Failure to confirm XMRV/MLVs in the blood of patients with chronic fatigue syndrome: a multi-laboratory study. Science 334: 814-817.
12. Dong B, Kim S, Hong S, Das Gupta J, Malathi K, et al. (2007) An infectious retrovirus susceptible to an IFN antiviral pathway from human prostate tumors. Proc Natl Acad Sci USA 104: 1655-1660.
13. Hong S, Klein EA, Das Gupta J, Hanke K, Weight CJ, et al. (2009) Fibrils of prostatic acid phosphatase fragments boost infections with XMRV (xenotropic murine leukemia virus-related virus), a human retrovirus associated with prostate cancer. J Virol 83: 6995-7003.
14. Ruscetti F, Lombardi V, Pfost M, Hagen K, Mikovits J, (2010) (2010) Repeated detection of infectious xenotropic murine virus-related virus (XMRV) in human neoplasia and neuroimmune diseases. 12th International Conference on Malignancies in AIDS and Other Acquired Immunodeficiencies. National Cancer Institute, Bethesda MD: Office of HIV and AIDS Malignancy. 23 p.http://oham.cancer.gov/objects/pdf/2010ICMAOI_Program_Book.pdf.
15. Barton M, (2011) Evaluating XMRV as an indicator of prostate cancer risk: Masters Thesis, Kent State University.http://rave.ohiolink.edu/etdc/view?acc_num=kent1309619878.
16. Haapala DK, Robey WG, Oroszlan SD, Tsai WP, (1985) Isolation from cats of an endogenous type C virus with a novel envelope glycoprotein. J Virol 53: 827-833.
17. Miller AD, Wolgamot G, (1997) Murine retroviruses use at least six different receptors for entry into Mus dunni cells. J Virol 71: 4531-4535.
18. Lo SC, Pripuzova N, Li B, Komaroff AL, Hung GC, et al. (2010) Detection of MLV-related virus gene sequences in blood of patients with chronic fatigue syndrome and healthy blood donors. Proc Natl Acad Sci USA 107: 15874-15879.
19. Miller AD, Bonham L, Alfano J, Kiem HP, Reynolds T, et al. (1996) A novel murine retrovirus identified during testing for helper virus in human gene transfer trials. J Virol 70: 1804-1809.
20. Bonham L, Wolgamot G, Miller AD, (1997) Molecular cloning of Mus dunni endogenous virus: an unusual retrovirus in a new murine viral interference group with a wide host range. J Virol 71: 4663-4670.
21. Miller AD, Bergholz U, Ziegler M, Stocking C, (2008) Identification of the myelin protein plasmolipin as the cell entry receptor for Mus caroli endogenous retrovirus. J Virol 82: 6862-6868.
22. Groom HCT, Boucherit VC, Makinson K, Randal E, Baptista S, et al. (2010) Absence of xenotropic murine leukaemia virus-related virus in UK patients with chronic fatigue syndrome. Retrovirology 7: 10.
23. Arnold RS, Makarova NV, Osunkoya AO, Suppiah S, Scott TA, et al. (2010) XMRV infection in patients with prostate cancer: novel serologic assay and correlation with PCR and FISH. Urology 75: 755-761.
24. Zhou Y, Steffen I, Montalvo L, Lee TH, Zemel R, et al. (2012) Development and application of a high-throughput microneutralization assay: lack of xenotropic murine leukemia virus-related virus and/or murine leukemia virus detection in blood donors. Transfusion 52: 332-342.
25. Rother RP, Fodor WL, Springhorn JP, Birks CW, Setter E, et al. (1995) A novel mechanism of retrovirus inactivation in human serum mediated by anti-α-galactosyl natural antibody. J Exp Med 182: 1345-1355.
26. Takeuchi Y, Porter CD, Strahan KM, Preece AF, Gustafsson K, et al. (1996) Sensitization of cells and retroviruses to human serum by (α1-3) galactosyltransferase. Nature 379: 85-88.
27. Takefman DM, Spear GT, Saifuddin M, Wilson CA, (2002) Human CD59 incorporation into porcine endogenous retrovirus particles: implications for the use of transgenic pigs for xenotransplantation. J Virol 76: 1999-2002.
28. Lander MR, Chattopadhyay SK, (1984) A Mus dunni cell line that lacks sequences closely related to endogenous murine leukemia viruses and can be infected by ecotropic, amphotropic, xenotropic, and mink cell focus-forming viruses. J Virol 52: 695-698.
29. Graham FL, Smiley J, Russell WC, Nairn R, (1977) Characteristics of a human cell line transformed by DNA from human adenovirus type 5. J Gen Virol 36: 59-74.
30. Mickey DD, Stone KR, Wunderli H, Mickey GH, Vollmer RT, et al. (1977) Heterotransplantation of a human prostatic adenocarcinoma cell line in nude mice. Cancer Res 37: 4049-4058.
31. Miller AD, Buttimore C, (1986) Redesign of retrovirus packaging cell lines to avoid recombination leading to helper virus production. Mol Cell Biol 6: 2895-2902.